search
Back to results

Functional Chewing Gum in Reduction of Gingival Inflammation

Primary Purpose

Gingivitis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Functional Chitosan Chewing Gum
Control Chewing Gum
Oral hygiene measures
Sponsored by
University of Maryland, Baltimore
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Gingivitis focused on measuring gingivitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Mild-moderate gingivitis
  • Minimum of 20 natural teeth

Exclusion Criteria:

  • Significant alveolar bone loss as evidenced by Bite-wings (>3.0 mm cementoenamel junction to bone)
  • Requirement for antibiotic pre-medication prior to dental procedures
  • Systemic antibiotic use in past 14 days to current.
  • Use of oral contraceptives
  • Use of anti-inflammatory (NSAIDs) or in past 14 days.
  • Use of anticoagulant therapy or in past 14 days.
  • Poorly controlled diabetes (HbA1c > 7.9%)*
  • Smoking
  • Pregnancy
  • Use of any oral rinses such as, but not limited to chlorhexidine, essential oils, cetylpyridinium chloride during the study.

Sites / Locations

  • University of Maryland School of Dentistry

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Functional chewing gum

Control chewing gum

Arm Description

Subjects given as intervention functional chewing gum device to supplement oral hygiene practices. Functional gum contains chitosan which is a food additive or generally recognized as safe food product. Individuals will use this gum 20 to 30 minutes three times per day. Subjects will brush and floss normally twice a day.

Subjects given control gum to supplement oral hygiene practices. Placebo gum does not contain any active ingredients. Individuals will use this gum 20 to 30 minutes three times per day. Subjects will brush and floss normally twice a day.

Outcomes

Primary Outcome Measures

Gum inflammation change
Measure the color of gingiva - use Gingiva Index

Secondary Outcome Measures

Plaque levels (on teeth) change
Measure plaque using Plaque Index

Full Information

First Posted
July 31, 2017
Last Updated
March 23, 2020
Sponsor
University of Maryland, Baltimore
search

1. Study Identification

Unique Protocol Identification Number
NCT03237624
Brief Title
Functional Chewing Gum in Reduction of Gingival Inflammation
Official Title
Use of a Functional Chewing Gum in Reduction of Gingival Inflammation
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
January 31, 2018 (Actual)
Primary Completion Date
January 31, 2020 (Actual)
Study Completion Date
January 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this prospective randomized 3-month double-blinded single center study is to determine whether a chewing gum device with food additive chitosan, will aid in reducing gingival inflammation by supplementing traditional tooth brushing and flossing measures. Patients with mild to moderate gingivitis will be identified and enrolled in this investigation. All enrolled subjects will receive baseline oral hygiene brushing instructions and a baseline clinical examination of the gingiva. The test group will utilize the test chewing gum three times a day for a minimum 20-30 minutes duration; the control group will receive a placebo gum and use it in a similar manner. We will examine whether daily use of a functional chewing gum enhances improvements to brushing and flossing.
Detailed Description
Periodontal disease remains a prevalent and preventable disease in man. Plaque bacterial biofilm remains the primary etiologic agent of disease; colonization of non-shedding tooth surfaces greatly contributes to initiation and progression of gingivitis, for example. Although there are currently available chemotherapeutic agents to supplement daily oral hygiene measures, one continuous issue is patient compliance. Chewing gum represents a unique delivery device for not only drugs and other agents, but food additives that might aid in reducing bacteria plaque colonization on tooth surfaces. For example, chitosan and chitosan-related food additive preparations have been shown to have some antimicrobial-like properties, possibly in the disruption of bacterial colonization (not -cidal). NOTE: ALL INGREDIENTS of the "test" chewing gum, and the placebo chewing gum, are generally regarded as safe ("GRAS" label by the Food and Drug Administration), as they are common food components. For example, chitosan is listed in the GRAS database (https://www.accessdata.fda.gov/scripts/fdcc/?set=SCOGS). See item GRN No. 397. This study aims to determine whether adjunctive use of functional chewing gum will improve gingival inflammation status-retaining clinical gains initiated by professional tooth cleaning and at home brushing over a 12 week period in gingivitis patients. Eligibility criteria and outcome measures are described in the next section.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gingivitis
Keywords
gingivitis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Functional chewing gum
Arm Type
Experimental
Arm Description
Subjects given as intervention functional chewing gum device to supplement oral hygiene practices. Functional gum contains chitosan which is a food additive or generally recognized as safe food product. Individuals will use this gum 20 to 30 minutes three times per day. Subjects will brush and floss normally twice a day.
Arm Title
Control chewing gum
Arm Type
Placebo Comparator
Arm Description
Subjects given control gum to supplement oral hygiene practices. Placebo gum does not contain any active ingredients. Individuals will use this gum 20 to 30 minutes three times per day. Subjects will brush and floss normally twice a day.
Intervention Type
Device
Intervention Name(s)
Functional Chitosan Chewing Gum
Intervention Description
Chitosan and chitosan-related preparations have been shown to have some antimicrobial properties, possibly in the disruption of bacterial colonization. It is thought that as a component of a functional chewing gum this will supplement in the removal of daily build up of dental plaque on tooth surfaces.
Intervention Type
Device
Intervention Name(s)
Control Chewing Gum
Intervention Description
Control chewing gum device does not have food additive chitosan in its composition.
Intervention Type
Behavioral
Intervention Name(s)
Oral hygiene measures
Intervention Description
Patients will be given instructions on how to brush and floss routinely (twice per day)
Primary Outcome Measure Information:
Title
Gum inflammation change
Description
Measure the color of gingiva - use Gingiva Index
Time Frame
Change in color of gingiva from baseline to 12 weeks
Secondary Outcome Measure Information:
Title
Plaque levels (on teeth) change
Description
Measure plaque using Plaque Index
Time Frame
Change in plaque level from baseline to 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Mild-moderate gingivitis Minimum of 20 natural teeth Exclusion Criteria: Significant alveolar bone loss as evidenced by Bite-wings (>3.0 mm cementoenamel junction to bone) Requirement for antibiotic pre-medication prior to dental procedures Systemic antibiotic use in past 14 days to current. Use of oral contraceptives Use of anti-inflammatory (NSAIDs) or in past 14 days. Use of anticoagulant therapy or in past 14 days. Poorly controlled diabetes (HbA1c > 7.9%)* Smoking Pregnancy Use of any oral rinses such as, but not limited to chlorhexidine, essential oils, cetylpyridinium chloride during the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Harlan Shiau, DDS
Organizational Affiliation
UMSOD
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Maryland School of Dentistry
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
23488873
Citation
Kaur S, Dhillon GS. The versatile biopolymer chitosan: potential sources, evaluation of extraction methods and applications. Crit Rev Microbiol. 2014 May;40(2):155-75. doi: 10.3109/1040841X.2013.770385. Epub 2013 Mar 14.
Results Reference
background
PubMed Identifier
25855683
Citation
Machul A, Mikolajczyk D, Regiel-Futyra A, Heczko PB, Strus M, Arruebo M, Stochel G, Kyziol A. Study on inhibitory activity of chitosan-based materials against biofilm producing Pseudomonas aeruginosa strains. J Biomater Appl. 2015 Sep;30(3):269-78. doi: 10.1177/0885328215578781. Epub 2015 Apr 8.
Results Reference
background
PubMed Identifier
20437720
Citation
Li Y, Lee S, Hujoel P, Su M, Zhang W, Kim J, Zhang YP, DeVizio W. Prevalence and severity of gingivitis in American adults. Am J Dent. 2010 Feb;23(1):9-13.
Results Reference
background
PubMed Identifier
10382579
Citation
Simons D, Beighton D, Kidd EA, Collier FI. The effect of xylitol and chlorhexidine acetate/xylitol chewing gums on plaque accumulation and gingival inflammation. J Clin Periodontol. 1999 Jun;26(6):388-91. doi: 10.1034/j.1600-051x.1999.260609.x.
Results Reference
background

Learn more about this trial

Functional Chewing Gum in Reduction of Gingival Inflammation

We'll reach out to this number within 24 hrs